TR

HYZON ANNOUNCES AGREEMENT WITH NEW ZEALAND'S LARGEST HEAVY-DUTY TRUCK FLEET OWNER

Retrieved on: 
Thursday, October 26, 2023

This new agreement cancels and supersedes a previously announced agreement from January 2021, providing a revised commercial path for TR Group's first Hyzon FCEV truck deployments.

Key Points: 
  • This new agreement cancels and supersedes a previously announced agreement from January 2021, providing a revised commercial path for TR Group's first Hyzon FCEV truck deployments.
  • "We look forward to deploying the first trucks with 200kW fuel cell systems produced by Hyzon in heavy-duty operations with TR Group.
  • It marks a significant step toward the full commercialization of our single stack 200kW fuel cell system," said Hyzon CEO Parker Meeks.
  • With 6,200 tractors in their fleet, TR Group would be a top-20 for-hire carrier in the U.S. based on fleet size1.

Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves

Retrieved on: 
Tuesday, October 24, 2023

Leaky valves in people with MR and TR can reduce the amount of blood being pumped through the body and make the heart work harder than it should.

Key Points: 
  • Leaky valves in people with MR and TR can reduce the amount of blood being pumped through the body and make the heart work harder than it should.
  • As a result, MR and TR can lead to other cardiovascular issues as well as severely limit a person's quality of life.
  • "For more than two decades, Abbott has continued to evolve and expand its minimally invasive treatment options for mitral and tricuspid regurgitation.
  • TriClip is approved for use in more than 50 countries, including in Europe and Canada, and is an investigational device in the U.S.

NEW PERFORMANCE-FOCUSED 2024 SUBARU WRX TR DEBUTS AT SUBIEFEST FLORIDA

Retrieved on: 
Friday, October 6, 2023

CAMDEN, N.J., Oct. 6, 2023 /PRNewswire/ -- The enthusiast-focused 2024 Subaru WRX TR will make its global debut at Subiefest Florida on Saturday, October 7.

Key Points: 
  • CAMDEN, N.J., Oct. 6, 2023 /PRNewswire/ -- The enthusiast-focused 2024 Subaru WRX TR will make its global debut at Subiefest Florida on Saturday, October 7.
  • With 2024 marking the return of the WRX TR to the model line, this top trim level will be available nationwide at Subaru retailers early next year.
  • The 2024 WRX TR will be unveiled at Subiefest Florida at Daytona International Speedway in Daytona, Florida to thousands of Subaru enthusiasts.
  • Pricing for the 2024 Subaru WRX TR will be announced later this year.

Vena Launches First Best-Practice Preconfigured Solution for Legal Firms in Partnership With ProLytics

Retrieved on: 
Wednesday, October 4, 2023

TORONTO, Oct. 4, 2023 /PRNewswire/ -- Vena, the Intelligent Complete Planning platform loved by finance and trusted by business, today announced Vena for Legal by ProLytics, a best-practice, preconfigured corporate performance management solution purpose-built to help law firms power flexible and more efficient financial, operational and strategic planning. ProLytics Consulting Group, the Vena Solutions Partner who developed this vertical solution on the Vena platform, is a consulting firm that specializes in performance management, data analytics and business intelligence. ProLytics will also implement the solution through its consultancy. 

Key Points: 
  • ProLytics Consulting Group, the Vena Solutions Partner who developed this vertical solution on the Vena platform, is a consulting firm that specializes in performance management, data analytics and business intelligence.
  • Vena for Legal by ProLytics provides proven methodologies for streamlining a firm's profitability analysis, offering cost and revenue transparency, and generating powerful insights into the firm's financial performance.
  • "Vena for Legal by ProLytics represents the first of the partner-built preconfigured solution we previewed at Excelerate 2023 ," said Allison Munro, Chief Marketing & Ecosystem Officer at Vena.
  • For more information about Vena for Legal by ProLytics, please visit www.venasolutions.com/industries/legal.

Vena Launches First Best-Practice Preconfigured Solution for Legal Firms in Partnership With ProLytics

Retrieved on: 
Wednesday, October 4, 2023

TORONTO, Oct. 4, 2023 /PRNewswire/ -- Vena, the Intelligent Complete Planning platform loved by finance and trusted by business, today announced Vena for Legal by ProLytics, a best-practice, preconfigured corporate performance management solution purpose-built to help law firms power flexible and more efficient financial, operational and strategic planning. ProLytics Consulting Group, the Vena Solutions Partner who developed this vertical solution on the Vena platform, is a consulting firm that specializes in performance management, data analytics and business intelligence. ProLytics will also implement the solution through its consultancy. 

Key Points: 
  • ProLytics Consulting Group, the Vena Solutions Partner who developed this vertical solution on the Vena platform, is a consulting firm that specializes in performance management, data analytics and business intelligence.
  • Vena for Legal by ProLytics provides proven methodologies for streamlining a firm's profitability analysis, offering cost and revenue transparency, and generating powerful insights into the firm's financial performance.
  • "Vena for Legal by ProLytics represents the first of the partner-built preconfigured solution we previewed at Excelerate 2023 ," said Allison Munro, Chief Marketing & Ecosystem Officer at Vena.
  • For more information about Vena for Legal by ProLytics, please visit www.venasolutions.com/industries/legal.

Trisol announces successful implants of its Transcatheter Tricuspid Valve in the US

Retrieved on: 
Wednesday, August 23, 2023

YOKNEAM, Israel, Aug. 23, 2023 /PRNewswire/ -- The heart teams at the Piedmont Heart Institute in Atlanta, Georgia, USA and the University of Virginia Health System in Charlottesville, VA, USA, successfully performed the first two implantations in the US of the Trisol Transcatheter Tricuspid Valve Replacement as part of a U.S. Food and Drug Administration approved Early Feasibility Study (EFS), led by Principal Investigator Isaac George, MD.

Key Points: 
  • We were able to abolish the patient's valvular heart disease via a minimally invasive procedure without the need for cardiopulmonary bypass.
  • Trisol patented valve features a distinctive design, that sets it apart from other tricuspid valves technologies.
  • Trisol valve is comprised of a single leaflet, the leaflet is affixed by 2 commissures enabling it to function as a bi-leaflet valve.
  • Five of these implants were performed as part of the Israeli Pilot Study, led by Principal Investigator Ran Kornowski, MD.

Trisol announces successful implants of its Transcatheter Tricuspid Valve in the US

Retrieved on: 
Wednesday, August 23, 2023

YOKNEAM, Israel, Aug. 23, 2023 /PRNewswire/ -- The heart teams at the Piedmont Heart Institute in Atlanta, Georgia, USA and the University of Virginia Health System in Charlottesville, VA, USA, successfully performed the first two implantations in the US of the Trisol Transcatheter Tricuspid Valve Replacement as part of a U.S. Food and Drug Administration approved Early Feasibility Study (EFS), led by Principal Investigator Isaac George, MD.

Key Points: 
  • We were able to abolish the patient's valvular heart disease via a minimally invasive procedure without the need for cardiopulmonary bypass.
  • Trisol patented valve features a distinctive design, that sets it apart from other tricuspid valves technologies.
  • Trisol valve is comprised of a single leaflet, the leaflet is affixed by 2 commissures enabling it to function as a bi-leaflet valve.
  • Five of these implants were performed as part of the Israeli Pilot Study, led by Principal Investigator Ran Kornowski, MD.

Laplace Interventional Inc. Announces first close of an Oversubscribed Series B Financing of $12.9M for its Transcatheter Tricuspid Valve Technology

Retrieved on: 
Tuesday, July 25, 2023

MINNEAPOLIS, July 24, 2023 /PRNewswire/ -- Minnesota based Laplace Interventional, a medical device company developing a transcatheter tricuspid valve technology, announced today that it has completed its first close on its Series B financing co-led by ShangBay Capital along with Features Capital, including participation from Engage Venture Partners, JWC Ventures as well as a global strategic investor. The $12.9M Series B financing will fund Laplace Interventional towards achieving its early clinical feasibility milestones. The company also announced that Jenny Barba, Co-Founder and Managing Partner at Features Capital, joined its Board of Directors and Todd Mortier, a serial MedTech entrepreneur had previously joined its Board of Directors.

Key Points: 
  • Laplace Interventional plans to use the funds raised from this round to pursue their First-in-Human (FIH) and clinical feasibility evaluation of its transcatheter valve system.
  • The $12.9M Series B financing will fund Laplace Interventional towards achieving its early clinical feasibility milestones.
  • Laplace Interventional's device is designed to offer an increase in life expectancy and an improvement to the quality of life to patients diagnosed with Tricuspid Regurgitation (TR).
  • Laplace Interventional is developing a prosthetic valve that will be delivered through through patient vasculature not requiring an open-heart surgery and thereby reducing complications in patients.

FCB Named North America Network of the Year for the Fifth Consecutive Year at Cannes Lions Festival

Retrieved on: 
Friday, June 23, 2023

CANNES, France, June 23, 2023 (GLOBE NEWSWIRE) -- FCB has been named North America Network of the Year for the fifth consecutive year at the 70th Annual Cannes Lions International Festival of Creativity.

Key Points: 
  • CANNES, France, June 23, 2023 (GLOBE NEWSWIRE) -- FCB has been named North America Network of the Year for the fifth consecutive year at the 70th Annual Cannes Lions International Festival of Creativity.
  • The network, which is celebrating its 150th anniversary this year, earned a total of 42 Lions throughout the Festival week, which included 2 Grand Prix, 6 Gold, 17 Silver and 17 Bronze Lions.
  • “To be named Cannes North America Network five years in a row is a testament to the belief our partners have in the economic value of creativity.
  • The work spotlights Chris Nikic, a man with Down syndrome who represents adidas’ first global sponsorship of a neurodivergent athlete.

Stran & Company Reports 28.7% Increase in Revenue for the First Quarter of 2023 and Achieves $15.8 Million in Revenue

Retrieved on: 
Monday, May 15, 2023

QUINCY, Mass., May 15, 2023 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today provided a business update and reported financial results for the three months ended March 31, 2023.

Key Points: 
  • Andy Shape, President and Chief Executive Officer of Stran, commented, “We are proud to report a 28.7% increase in revenue to $15.8 million for the first quarter of 2023.
  • Promotions”), and also entered into a definitive agreement to acquire T R Miller Co., Inc. (“TR Miller”) as announced in January.
  • The increase in the dollar amount of gross profit was due to increased sales, partially offset by an increase in purchasing costs.
  • A webcast replay will be available on the company’s Investors section of the website ( ir.stran.com/news-events/ir-calendar ) through, May 15, 2024.